Sunday, November 1, 2026

Less Than Two Hours Before The NASDAQ Open, Smith & Wesson Is Up By 4%

Less Than Two Hours Before The NASDAQ Open, Smith & Wesson Is Up By 4%

(VIANEWS) - The NASDAQ opens in less than two hours and Smith & Wesson's pre-market value is already 4.96% up.

Smith & Wesson's last close was $11.90, 28.83% below its 52-week high of $16.72.

The last session, NASDAQ ended with Smith & Wesson (SWBI) falling 2.06% to $11.90. NASDAQ fell 1.07% to $11,996.86, after three consecutive sessions in a row of losses, on what was an all-around bearish trend trading session.

About Smith & Wesson

Smith & Wesson Brands, Inc. designs, manufactures, and sells firearms worldwide. The company offers handguns, including revolvers and pistols; long guns, such as modern sporting rifles, bolt action rifles; handcuffs; suppressors; and other firearm-related products under the Smith & Wesson, M&P, and Gemtech brands. It also provides manufacturing services comprising forging, heat treating, rapid prototyping, tooling, finishing, plating, machining, and custom plastic injection molding to other businesses under the Smith & Wesson and Smith & Wesson Precision Components brand names; and sells parts purchased through third parties. The company sells its products to firearm enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement, security agencies and officers, and military agencies. It markets its products through independent dealers, retailers, in-store retails, and direct to consumers; print, broadcast, and digital advertising campaigns; social and electronic media; and in-store retail merchandising strategies. Smith & Wesson Brands, Inc. was founded in 1852 and is based in Springfield, Massachusetts.

Earnings Per Share

As for profitability, Smith & Wesson has a trailing twelve months EPS of $5.43.

PE Ratio

Smith & Wesson has a trailing twelve months price to earnings ratio of 2.19. Meaning, the purchaser of the share is investing $2.19 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.28%.

Growth Estimates Quarters

The company's growth estimates for the current quarter and the next is a negative 68.1% and a negative 63.4%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth declined by 47.5%, now sitting on 564.47M for the twelve trailing months.

Sales Growth

Smith & Wesson's sales growth is negative 29.5% for the current quarter and negative 25.1% for the next.

Yearly Top and Bottom Value

Smith & Wesson's stock is valued at $11.90 at 08:27 EST, way under its 52-week high of $16.72 and way above its 52-week low of $8.21.

More news about Smith & Wesson (SWBI).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Goes Operational: Platform Governance, Local Silicon, and the Physical-AI Data Race
In mid-to-late October 2026, enterprise vendors (Cisco, Fortinet, ServiceNow, Intuit, Salesforce/Braze, Adobe) shipped agent governance, AI security and AI-driven customer engagement products, while a parallel hardware wave (NVIDIA RTX Spark laptops, ASUS, Apple's iPad mini, Microsoft's hybrid local/cloud Windows) pushed AI onto local devices. A third strand, physical AI (Encord, Harvest Praxis, Hesai), argues that real-world sensor data and cheaper edge chips are the next bottleneck. The common thread is the shift from AI experimentation to governed, scaled deployment, with Salesforce's Braze acquisition showing consolidation and fintech players like Intuit tying AI to trusted financial data. The facts support a broad industry theme but contain little direct finance or regulatory evidence, so the AI-finance angle is thin.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,532 source documents archived
Query this data → isubstrate.com